Security key
19249H103
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 76,943,748
- Total 13F value
- $79,924,458
- Share change
- -5,673,419
- Put/Call ratio
- 123%
- SEC-reported price per share
- $1.04
- Number of holders
- 127
- Value change
- -$11,982,900
- Number of buys
- 54
- Number of sells
- 53
- Shares outstanding
- 154,050,897
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
127
Top holders
10
CHRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Coherus Oncology, Inc. SEC filings
Coherus Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19249H103
Recent filing periods:
Ownership snapshot
Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 7.6%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 7.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
7.6%
VANGUARD GROUP INC
6.9%
Rubric Capital Management LP
6.8%
Temasek Holdings (Private) Ltd
3.8%
Kohlberg Kravis Roberts & Co. L.P.
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
7.6%
|
$20,331,825
11,752,500 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
6.9%
|
$18,342,133
10,602,389 shares
|
— | 30 Jun 2024 |
| Rubric Capital Management LP |
13F
Company
|
6.8%
|
$17,992,000
10,400,000 shares
|
— | 30 Jun 2024 |
| Temasek Holdings (Private) Ltd |
13F
Company
|
3.8%
|
$10,066,527
5,818,802 shares
|
— | 30 Jun 2024 |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
Company
|
2%
|
$5,252,413
3,036,076 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.8%
|
$4,919,165
2,843,448 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
127
Shares
76,943,748
Rows available
127
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
132
Q3 2024 holders
127
Holder diff
-5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend